Satellite Symposium - Reimagining the MS treatment journey
ECTRIMS Learn. Presenters F. 09/14/16; 147372; 302
Faculty / Presenters
Abstract
Chairs
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
Supported by Merck
Presentations
86 - Opening and welcome Evolving therapeutic landscape: do we still have unmet needs?
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
18:45 – 18:55
87 - Debate: do we still have unmet needs in multiple sclerosis?
G. Giovannoni, London, United Kingdom
H. Wiendl, Münster, Germany
18:55 – 19:15
88 - What are we looking for in a multiple sclerosis therapy?
H. Wiendl, Münster, Germany
19:15 – 19:25
89 - Current and future therapies: are we getting closer to addressing the unmet needs?
S. Schippling, Zurich, Switzerland
19:25 – 19:40
90 - Summary and close
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
19:40 – 19:45
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
Supported by Merck
Presentations
86 - Opening and welcome Evolving therapeutic landscape: do we still have unmet needs?
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
18:45 – 18:55
87 - Debate: do we still have unmet needs in multiple sclerosis?
G. Giovannoni, London, United Kingdom
H. Wiendl, Münster, Germany
18:55 – 19:15
88 - What are we looking for in a multiple sclerosis therapy?
H. Wiendl, Münster, Germany
19:15 – 19:25
89 - Current and future therapies: are we getting closer to addressing the unmet needs?
S. Schippling, Zurich, Switzerland
19:25 – 19:40
90 - Summary and close
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
19:40 – 19:45
Chairs
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
Supported by Merck
Presentations
86 - Opening and welcome Evolving therapeutic landscape: do we still have unmet needs?
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
18:45 – 18:55
87 - Debate: do we still have unmet needs in multiple sclerosis?
G. Giovannoni, London, United Kingdom
H. Wiendl, Münster, Germany
18:55 – 19:15
88 - What are we looking for in a multiple sclerosis therapy?
H. Wiendl, Münster, Germany
19:15 – 19:25
89 - Current and future therapies: are we getting closer to addressing the unmet needs?
S. Schippling, Zurich, Switzerland
19:25 – 19:40
90 - Summary and close
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
19:40 – 19:45
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
Supported by Merck
Presentations
86 - Opening and welcome Evolving therapeutic landscape: do we still have unmet needs?
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
18:45 – 18:55
87 - Debate: do we still have unmet needs in multiple sclerosis?
G. Giovannoni, London, United Kingdom
H. Wiendl, Münster, Germany
18:55 – 19:15
88 - What are we looking for in a multiple sclerosis therapy?
H. Wiendl, Münster, Germany
19:15 – 19:25
89 - Current and future therapies: are we getting closer to addressing the unmet needs?
S. Schippling, Zurich, Switzerland
19:25 – 19:40
90 - Summary and close
D. Bates, Newcastle upon Tyne, United Kingdom
G. Giovannoni, London, United Kingdom
19:40 – 19:45
{{ help_message }}
{{filter}}